BEAM
Price
$25.42
Change
+$0.03 (+0.12%)
Updated
Oct 14 closing price
Capitalization
2.57B
26 days until earnings call
Intraday Buy/Sell Signals
KZR
Price
$4.33
Change
+$0.04 (+0.93%)
Updated
Oct 14 closing price
Capitalization
31.71M
Intraday Buy/Sell Signals
Interact to see
Advertisement

BEAM vs KZR

Header iconBEAM vs KZR Comparison
Open Charts BEAM vs KZRBanner chart's image
Beam Therapeutics
Price$25.42
Change+$0.03 (+0.12%)
Volume$2.03M
Capitalization2.57B
Kezar Life Sciences
Price$4.33
Change+$0.04 (+0.93%)
Volume$82.82K
Capitalization31.71M
BEAM vs KZR Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. KZR commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and KZR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (BEAM: $25.42 vs. KZR: $4.33)
Brand notoriety: BEAM and KZR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 75% vs. KZR: 201%
Market capitalization -- BEAM: $2.57B vs. KZR: $31.71M
BEAM [@Biotechnology] is valued at $2.57B. KZR’s [@Biotechnology] market capitalization is $31.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileKZR’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • KZR’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than KZR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while KZR’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • KZR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BEAM and KZR are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а +1.15% price change this week, while KZR (@Biotechnology) price change was +12.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.57B) has a higher market cap than KZR($31.7M). BEAM YTD gains are higher at: 2.500 vs. KZR (-35.565). KZR has higher annual earnings (EBITDA): -68.34M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. KZR (101M). KZR has less debt than BEAM: KZR (12.1M) vs BEAM (155M). BEAM has higher revenues than KZR: BEAM (60.3M) vs KZR (0).
BEAMKZRBEAM / KZR
Capitalization2.57B31.7M8,114%
EBITDA-414.33M-68.34M606%
Gain YTD2.500-35.565-7%
P/E RatioN/AN/A-
Revenue60.3M0-
Total Cash1.15B101M1,139%
Total Debt155M12.1M1,281%
FUNDAMENTALS RATINGS
KZR: Fundamental Ratings
KZR
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMKZR
RSI
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 8 days ago
90%
Momentum
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 8 days ago
70%
MACD
ODDS (%)
N/A
Bullish Trend 8 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 8 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 8 days ago
79%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 10 days ago
73%
Declines
ODDS (%)
Bearish Trend 20 days ago
85%
Bearish Trend 17 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
90%
Aroon
ODDS (%)
Bullish Trend 8 days ago
75%
Bearish Trend 8 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PIII9.090.44
+5.09%
P3 Health Partners Inc
LPRO2.020.05
+2.54%
Open Lending Corp
RES4.32N/A
N/A
RPC
FRO22.01-0.78
-3.42%
Frontline Plc
CRWV134.06-7.56
-5.34%
Coreweave Inc

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.12%
CRSP - BEAM
66%
Closely correlated
+1.60%
NTLA - BEAM
63%
Loosely correlated
+0.59%
RXRX - BEAM
61%
Loosely correlated
+6.51%
PRME - BEAM
55%
Loosely correlated
+6.02%
ABSI - BEAM
54%
Loosely correlated
+6.56%
More

KZR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZR has been loosely correlated with CTMX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if KZR jumps, then CTMX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZR
1D Price
Change %
KZR100%
+0.93%
CTMX - KZR
34%
Loosely correlated
+0.59%
TECH - KZR
33%
Loosely correlated
-0.64%
GLTO - KZR
33%
Loosely correlated
-10.98%
DNLI - KZR
33%
Poorly correlated
+1.54%
BEAM - KZR
32%
Poorly correlated
+0.12%
More